Search

Search Constraints

You searched for: Author/Creator Ieluzzi, Donatella

Search Results

1. A NEW VISION OF NON-ALCOHOLIC FATTY LIVER DISEASE: A "CARDIAC" DISEASE PER SE AND A "VASCULAR" DISEASE ONLY WITH HYPERTENSION. (April 2021)

2. A prospective study of direct‐acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort. Issue 1 (19th January 2022)

3. Beneficial effects of DAAs on cardiac function and structure in hepatitis C patients with low‐moderate liver fibrosis. Issue 11 (13th August 2020)

4. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort. Issue 12 (December 2021)

5. Effects of direct‐acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real‐life Italian experience. Issue 5 (11th July 2022)

6. Forecasting Hepatitis C liver disease burden on real‐life data. Does the hidden iceberg matter to reach the elimination goals?. (10th August 2018)

7. Modeling cost‐effectiveness and health gains of a "universal" versus "prioritized" hepatitis C virus treatment policy in a real‐life cohort. Issue 6 (30th October 2017)

8. Protease inhibitors‐based therapy induces acquired spherocytic‐like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients. (14th July 2015)

9. Reliable prediction of clinical outcome in patients with chronic HCV infection and compensated advanced hepatic fibrosis: a validated model using objective and readily available clinical parameters. Issue 2 (9th May 2014)